Aim: The role of viral infections in the exacerbations of chronic obstructive pulmonary disease (COPD) remains controversial. The rates of recent viral infections vary from 23 to 62%; moreover pathogens as Chlamydophila pneumoniae are often detected in patients with COPD during an exacerbation. Investigating the impact of viral infections in COPD exacerbations, a study was conducted in an Athenian hospital of Greece. Patients-Methods: All patients suffered from exacerbation of COPD (n=87), as well as from pneumonia and COPD (n=17).Seventy healthy volunteers were also assessed at the same time (comparison group). In all examinations we measured IgM blood antibodies for influenza A & B, RSV, parainfluenza viruses, Mycoplasma pneumoniae and Chlamydophila pneumoniae. Sputum cultures and bacteria taken from all patients were evaluated if > 105cfu/ml. Results: Sputum cultures revealed bacterial pathogens in a 40% of all patients but still only in three cases these were responsible for the presence of pneumonia. A comparison between patients with exacerbations of COPD and healthy volunteers revealed a statistical increase of IgM for influenza A virus and Mycoplasma pneumoniae. As far as patients with COPD exacerbations were concerned the difference was almost significant for RSV and influenza B but not significant for Chlamydophila pneumoniae. Moreover, there was not detected such a difference between patients with pneumonia and COPD, and patients with COPD exacerbations. Conclusions: The incidence of bacterial colonization in patients with COPD exacerbations attempts to draw the attention of the physician to the prudent use of antibiotics in patients with COPD.
INTRODUCTION
Chronic obstructive pulmonary disease (COPD) is determined, following the GOLD (Global initiative on obstructive lung disease) criteria, as the non-reversible decrease in pulmonary airflow. The pathogenicity of COPD includes chronic inflammatory response to exogenous antigens (i.e. Toxic particulates and gases) [ 1 , 2 , 3 ] . Every patient with a history of smoking, chronic productive cough and dyspnoea has to be examined for COPD, which is currently a disease preventable and treatable. Diagnosis is established by spirometry (FEV1/FVC < 70%) [ 3 , 4 ] . COPD is a major cause of morbidity and mortality worldwide [ 2 , 3 , 4 ]. More than 23.000.000 people in the USA (14% of population) suffer from this disease with an annual rate of 119.000 attributed deaths. Overall the real incidence of COPD is underestimated [ 2 , 3 ] .COPD has increased more than 40% since 1982 being the 5 th cause of death in the USA [ 3 , 4 , 5 ]. According to WHO in 2020, COPD is globally predicted to be the 3d more frequent cause of death [ 5 , 6 ].
COPD is characterized by exacerbations that promote the gradual impairment of pulmonary function and the need for frequent hospitalizations bearing a significant devaluation in the patient's quality of life. Every episode of exacerbation deteriorates previous pulmonary condition and is classified as mild, moderate and severe and frequently requires hospitalization [ 7 ] . Bacterial and viral infections are considered as the major cause of COPD exacerbation especially in the initial phase of the disease. Viral infections are implicated in COPD exacerbations in 25-63% of cases [ 2 , 6 , 7 ] .
It is also difficult to demonstrate the presence of an infectious agent during the COPD exacerbation for many reasons and mainly because the definition of COPD exacerbation is not always clear.
According to published data, COPD exacerbation is defined as the change in the quality and /or quantity of sputum production [ 7 ] . Moreover, microorganisms that belong to normal flora of the mouth and pharynx may be isolated in the sputum during COPD exacerbation in the absence of clinical signs of infection. This is a confounding factor in the etiology of COPD exacerbation. [ 6 , 7 ] . In an attempt to contribute to the current knowledge on the role of viral infections in COPD exacerbations, this study was conducted in Sotiria Chest Hospital in Athens, Greece.
PATIENTS-METHODS
A prospective case-control study was undertaken. In the study included 104 adult patients (80 male, 24 female) with diagnosis of COPD who were hospitalized for COPD exacerbation or pneumonia in Sotiria Lung Hospital. During the same period at the same hospital, seventy healthy volunteers (30 male and 40 female) voluntarily participated in the control group. All participants were informed over the point of view of this study which was approved by the Ethics Committee of the Hospital.
Study definitions: The inflammatory process of the lung caused by an infective micro-organism was defined as pneumonia [ 8 , 9 ] . Only COPD patients with communityacquired pneumonia (CAP) took part in the study. Cases of hospital acquired pneumonia or ventilator-associated pneumonia were excluded.
Deterioration of dyspnoea, including the increased volume of sputum and the presence of pus, gave the definition of COPD exacerbation according to Anthonisen criteria [ 10 ] . Following these criteria, patients with COPD are classified in 3 groups: a) Group I is characterized by dyspnoea, increased sputum production and purulent sputum. b) Group II by 2 of the previous symptoms. c) Group III by only one of the previously described symptoms.
Quantitative sputum cultures detected bacteria possibly implicated in COPD exacerbations and pneumonia in all patients according to routine microbiological standard procedures. Only pathogens in a concentration of > 10 5 cfu/ml were evaluated.
Blood gases analysis was performed in all patients at their hospital admission and their discharge. Inflammatory laboratory markers as CRP were measured in all patients.
Chest radiographs evaluated at hospital admission and on discharge. A computed lung tomography was performed in 4 cases: a) in order to exclude underlying malignancy b) for radiological diagnosis of pulmonary emphysema whenever x-ray was not diagnostic c) Diagnosis of brochiectasis d) in every case that x-ray was not diagnostic.
The clinical condition (the onset of symptoms, fever>38 o C, dyspnoea, expectoration with sputum production -purulent or not-) on admission was assessed in all the participants in this study.
A history of prior hospitalizations (in wards and ICU) due to COPD exacerbation or pneumonia was also recorded. In conclusion, the role of virus and atypical pathogens in COPD exacerbations remains obscure. Mycoplasma spp is a rare cause of exacerbations (not exceeding 14% of cases). Legionella pneumophila did not correlate with COPD exacerbations, unless of some geographic regions where the disease is endemic [ 30 ] .
The main advantage of this study is the comparison of healthy volunteers in the same geographic region at the same season. Patients with pneumonia and patients with COPD exacerbations did not differ in terms of serology investigation while patients with exacerbations of COPD had a significant higher prevalence of positive serology for influenza and Mycoplasma than controls. This is an indication that in the examined population, recent viral infection might be involved in the pathogenesis of COPD acute exacerbations.
